HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Amitriptyline Hydrochloride

HCID 11065
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
549-18-8
Standard SMILES
CN(C)CCC=C1c2ccccc2CCc2ccccc21.Cl
InChIKey
KFYRPLNVJVHZGT-UHFFFAOYSA-N
Molecular formula
C20H24ClN
Average molar mass
313.9 g/mol
Monoisotopic mass
313.1597275

Overview

Amitriptyline hydrochloride is an organic tricyclic compound.

Names & identifiers

Preferred name
Amitriptyline Hydrochloride
IUPAC
N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine;hydrochloride
English name
Amitriptyline hydrochloride
Molecular formula
C20H24ClN
Molecular weight
313.86

Names & synonyms

Amitriptyline hydrochloride549-18-8Amitriptyline HClEtravilSyneudonNovoprotectAmitidAmitrilSaroten RetardNIH 10794CytriptylineDTXSID9033187
Show more names
endepAmitriptyline Hydrochloride (200 mg)deprexNormalnAmiplindomicaletrafonsaroten
Amitriptylini hydrochloridum26LUD4JO9KNSC-1042101-Propanamine, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochlorideDTXCID7013187NSC104210NSC1699101-propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride

Database identifiers

CAS
549-18-8
PubChem CID
11065
DTXSID
DTXSID9033187
ChEMBL
CHEMBL1200964
ChEBI
CHEBI:2667
UNII
26LUD4JO9K
EC Number
208-964-6

Properties

Computed structural properties

Topological polar surface area
3.2 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
1
Rotatable bonds
3
Heavy atoms
22
Formal charge
0
Complexity
331

Experimental & physicochemical properties

Solubility>47.1 [ug/mL] (The mean of the results at pH 7.4)
Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section166.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
196 · 196-197°C
Flash point
11 °C · 11 °C
storage temp.
2 · 2-8°C
solubility
2 O: · H2O: soluble
form
powder
pka
9.4 · 9.4(at 25℃)
color
white to off-white
PH
4.5 · 4.5~6.0 (10g/l, 25℃)
Water Solubility
almost transparency
Merck
14 · 14,487

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 0.7% (1 of 136) of reports.

Danger

H301 (71.3%): Toxic if swallowed [Danger Acute toxicity, oral]

P203, P260, P263, P264, P264+P265, P270, P273, P280, P301+P316, P301+P317, P305+P351+P338, P305+P354+P338, P308+P316, P317, P318, P321, P330, P337+P317, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 136 reports by companies from 21 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information · 2 items

REACH registered substance: Amitriptyline hydrochloride (EC: 208-964-6)

Amitriptyline hydrochloride: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - 1-Propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride: Human health tier I assessment
Hazard Classes and CategoriesAcute Tox. 3 (71.3%)

Toxicology

Treatment · 1 item

Consider gastric lavage only if within one hour of a potentially fatal overdose. Give 50 grams of charcoal if within one hour of ingestion. Prolonged resuscitation may be successful in case of cardiac arrest. Give sodium bicarbonate in case of arrhythmias. (A311)

Health Effects · 1 item

Chemistry & industry

Pharmacology

Metabolism/Metabolites · 1 item

Amitriptyline is rapidly and well absorbed following oral administration. Exclusively hepatic, with first pass effect. Amitriptyline is demethylated in the liver to its primary active metabolite, nortriptyline. Route of Elimination: Virtually the entire dose is excreted as glucuronide or sulfate conjugate of metabolites, with little unchanged drug appearing in the urine. 25-50% of a single orally administered dose is excreted in urine as inactive metabolites within 24 hours. Small amounts are excreted in feces via biliary elimination. Half Life: 10 to 50 hours, with an average of 15 hours

FDA Pharmacological Classification · 4 items

AMITRIPTYLINE HCL

Tricyclic Antidepressant [EPC]

AMITRIPTYLINE HYDROCHLORIDE

Tricyclic Antidepressant [EPC]

MeSH Pharmacological Classification · 3 items

Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.

A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS.

Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin.

Uses & manufacturing

UsesFor the treatment of depression, chronic pain, irritable bowel syndrome, sleep disorders, diabetic neuropathy, agitation and insomnia, and migraine prophylaxis.

Related reactions

2 records
New reaction record
HRID 990584 reaction equation
HRID 990584As reactant
HRID 990585 reaction equation
HRID 990585As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Henry's Law Constant
1.4 · 1.4×102 mol/(m3Pa) at 25℃, HSDB (2015)
BCS Class
1 · 1
InChI
InChI=1S/C20H23N.ClH/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20;/h3-6,8-12H,7,13-15H2,1-2H3;1H
InChIKey
KFYRPLNVJVHZGT-UHFFFAOYSA-N
SMILES
CN(CC/C=C1/C2=C(C=CC=C2)CCC2=C/1C=CC=C2)C.[H]Cl
CAS DataBase Reference
549 · 549-18-8(CAS DataBase Reference)
NCI Dictionary of Cancer Terms
amitriptyline hydrochloride
FDA UNII
26 LUD4JO9K · 26LUD4JO9K
NCI Drug Dictionary
amitriptyline hydrochloride
EPA Substance Registry System
Amitriptyline hydrochloride (549-18-8)
UNSPSC Code
41116107 · 41116107
NACRES
77 · NA.77
Protein binding
96 % · 96%
Excreted unchanged in urine
2 % · <2%
Volume of distribution
6 · 6-36(L/kg)
Biological half-life
9 · 9-25 / Unchanged
Symbol(GHS)
6 · GHS06,GHS08,GHS09
Signal word
Danger
Hazard statements
301 · H301-H319-H361d-H410
Precautionary statements
202 · P202-P264-P270-P273-P301+P310-P305+P351+P338
PPE
3 · Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
Hazard Codes
T,F,N,Xn
Risk Statements
23 · 23/24/25-36/37/38-42/43-63-39/23/24/25-11-50/53-36-22
Safety Statements
22 · 22-26-36/37/39-45-36/37-16-61-60-7
RIDADR
2811 · UN 2811 6.1/PG 3
WGK Germany
3 · 3
RTECS
9450000 · HO9450000
TSCA
TSCA listed
HazardClass
6.1 · 6.1(b)
PackingGroup
III
HS Code
29214990 · 29214990
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
3 OralAquatic · Acute Tox. 3 OralAquatic Acute 1Aquatic Chronic 1Eye Irrit. 2Repr. 2
Toxicity
50 in · LD50 in mice, rats (mg/kg): 350, 380 orally; 65, 75 i.p. (Tobe)
REACH Registrations
Active

Some rare side effects include tinnitus, hypotension, mania, psychosis, heart block, arrhythmias, lip and mouth ulcers, extrapyramidal symptoms, depression, and hepatic toxicity.Amitriptyline exhibits strong anticholinergic activity, cardiovascular effects including orthostatic hypotension, changes in heart rhythm and conduction, and a lowering of the seizure threshold (A308, L1032).

Exposure RoutesOral (A308) Rapidly and well absorbed following oral administration (bioavailability is 30-60% due to first pass metabolism). Peak plasma concentrations occur 2-12 hours following oral or intramuscular administration.
Toxicity Summary · 1 item

Amitriptyline is metabolized to nortriptyline which inhibits the reuptake of norepinephrine and serotonin almost equally. Amitriptyline inhibits the membrane pump mechanism responsible for uptake of norepinephrine and serotonin in adrenergic and serotonergic neurons. Pharmacologically this action may potentiate or prolong neuronal activity since reuptake of these biogenic amines is important physiologically in terminating transmitting activity. This interference with the reuptake of norepinephrine and/or serotonin is believed by some to underlie the antidepressant activity of amitriptyline.

Signs and Symptoms · 1 item

Symptoms of overdose include abnormally low blood pressure, confusion, convulsions, dilated pupils and other eye problems, disturbed concentration, drowsiness, hallucinations, impaired heart function, rapid or irregular heartbeat, reduced body temperature, stupor, and unresponsiveness or coma. Side effects include: sedation, hypotension, blurred vision, dry mouth, constipation, urinary retention, postural hypotension, tachycardia, hypertension, ECG changes, heart failure, impaired memory and delirium, and precipitation of hypomanic or manic episodes in bipolar depression. Withdrawal symptoms include gastrointestinal disturbances, anxiety, and insomnia.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Amitriptyline hydrochloride

vLess-DILI-concern

5

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Toxicity DataLD50: 350 mg/kg (Oral, Mouse) (A308)

Safety data

PPE
Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
wgk
3
tsca
TSCA listed
rtecs
HO9450000
ridadr
UN 2811 6.1/PG 3
hs_code
29214990
Toxicity
LD50 in mice, rats (mg/kg): 350, 380 orally; 65, 75 i.p. (Tobe)
risk_code
23/24/25-36/37/38-42/43-63-39/23/24/25-11-50/53-36-22
Signal word
Danger
Symbol(GHS)
GHS06,GHS08,GHS09
hazard_code
T,F,N,Xn
safety_code
22-26-36/37/39-45-36/37-16-61-60-7
hazard_class
6.1(b)
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
packing_group
III
Hazard statements
H301-H319-H361d-H410
REACH Registrations
Active
Hazard Classifications
Acute Tox. 3 OralAquatic Acute 1Aquatic Chronic 1Eye Irrit. 2Repr. 2
Precautionary statements
P202-P264-P270-P273-P301+P310-P305+P351+P338
General Manufacturing Information1-Propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride (1:1): INACTIVE
Applications · 5 items

DescriptionAmitriptyline (hydrochloride) (CRM) (Item No. 19031) is a certified reference material categorized as a tricyclic antidepressant. This product is intended for analytical forensic applications. This product is also available as a general research tool .

Usesvasoconstrictor

UsesAmitriptyline hydrochloride is a tricyclic antidepressant drug. Amitriptyline hydrochloride inhibits the norepinephrine and serotonin transporters but has a high affinity for α1-adrenergic, serotonin and muscarinic acetylcholine receptors.

UsesAmitriptyline hydrochloride has been used:as an antidepressant to study its effects on social behavior and memory in transgenic for acid sphingomyelinase (t-ASM) miceas a tricyclic antidepressant to analyze its effects on glucocorticoid receptor function in whole human bloodas an anti-depressant to study its effects on scratching and locomotion behavior in chloroquine-induced mouse

General DescriptionAmitriptyline, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine hydrochloride,5-(3-dimethylaminopropylidene)-10,11-dihydro-5Hdibenzo[a,d]cycloheptene hydrochloride (Elavil), is one ofthe most anticholinergic and sedative of the TCAs. Becauseit lacks the ring-electron–enriching nitrogen atom ofimipramine, metabolic inactivation mainly proceeds not at theanalogous 2-position but at the benzylic 10-position (i.e.,toluene-like metabolism predominates). Because of the 5-exocyclic double bond, E- and Z-hydroxy isomers are producedby oxidation metabolism. Conjugation produces excretablemetabolites. As is typical of the dimethyl compounds,N-demethylation occurs, and nortriptyline is produced, whichhas a less anticholinergic, less sedative, and more stimulantaction than amitriptyline. Nortriptyline is a SNERI; thecomposite action of drug and metabolite is nonselective.

Upstream & downstream products

Upstream raw materials

Acetyl keteneAmitriptylineDiethyl etherAmmonium chlorideDilute hydrochloric acidPhosphorus pentoxidePhenylacetic acidHydrogenHydrochloric acidPhthalic anhydride3-Chloro-1-(N,N-dimethyl)propylamine

Additional notes

DefinitionChEBI: Amitriptyline hydrochloride is an organic tricyclic compound.